Zhu, J., K. Li, L. Yu, Y. Chen, Y. Cai, J. Jin, et al. 2021. Targeting phosphatidylinositol 3-kinase gamma (PI3Kgamma): Discovery and development of its selective inhibitors. Medicinal Research Reviews 41:1599–1621.

Article  CAS  PubMed  Google Scholar 

Nürnberg, Beer-Hammer. 2019. Function, Regulation and Biological Roles of PI3Kγ Variants. Biomolecules 9: 427.

Article  PubMed  PubMed Central  Google Scholar 

Bauer, T. M., M. R. Patel, and J. R. Infante. 2015. Targeting PI3 kinase in cancer. Pharmacology & Therapeutics 146:53–60.

Article  CAS  Google Scholar 

Jiang, Y., W. Xiong, L. Jia, L. Xu, Y. Cai, Y. Chen, et al. 2022. Developing a Naive Bayesian Classification Model with PI3Kgamma structural features for virtual screening against PI3Kgamma: Combining molecular docking and pharmacophore based on multiple PI3Kgamma conformations. European Journal of Medicinal Chemistry 244:114824.

Article  CAS  PubMed  Google Scholar 

Jia, L., L. Wang, Y. Jiang, L. Xu, Y. Cai, Y. Chen, et al. 2022. Exploring PI3Kgamma binding preference with Eganelisib, Duvelisib, and Idelalisib via energetic, pharmacophore and dissociation pathway analyses. Computers in Biology and Medicine 147:105642.

Article  CAS  PubMed  Google Scholar 

Jingyu, Zhu, Hou Tingjun, and Mao Xinliang. 2015. Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies. Drug Discovery Today 20:988–994.

Article  Google Scholar 

Cushing, T. D., D. P. Metz, et al. 2012. PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases. Journal of Medicinal Chemistry 55:8559–8581.

Article  CAS  PubMed  Google Scholar 

Xiong, W. D., L. Jia, Y. F. Cai, Y. Chen, J. Jin, and J. Y. Zhu. 2023. Investigation Into The Anti-inflammation and PI3K? Inhibitory Preference of Eganelisib. Progress in Biochemistry and Biophysics 50:1971–1981.

Google Scholar 

Williams, O., B. Houseman, T. Kunkel, et al. 2010. Discovery of dual inhibitors of the immune cell PI3Ks p110d and p110g: a prototype for new anti-inflammatory drugs. Chemistry & Biology 17:123–134.

Article  CAS  Google Scholar 

Lanahan, S. M., M. P. Wymann, and C. L. Lucas. 2022. The role of PI3Kgamma in the immune system: New insights and translational implications. Nature Reviews Immunology 22:687–700.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henau, O. D., M. Rausch, D. Winkler, L. F. Campesato, C. Liu, D. H. Cymerman, et al. 2016. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells. Nature 539:443–447.

Article  PubMed  PubMed Central  Google Scholar 

Kaneda, M. M., K. S. Messer, N. Ralainirina, H. Li, C. J. Leem, S. Gorjestani, et al. 2016. PI3Kγ is a molecular switch that controls immune suppression. Nature 539:437–442.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cirillo, D., M. Diceglie, and M. Nazaré. 2023. Isoform-selective targeting of PI3K: Time to consider new opportunities? Trends in Pharmacological Sciences 44:601–621.

Article  CAS  PubMed  Google Scholar 

Papi, A., C. Brightling, S.E. Pedersen, and H.K. Reddel. 2018. Asthma. The Lancet 391:783–800.

Article  Google Scholar 

Akar-Ghibril, N., T. Casale, A. Custovic, and W. Phipatanakul. 2020. Allergic Endotypes and Phenotypes of Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:429–440.

PubMed  Google Scholar 

Gandhi, N. A., B. L. Bennett, N. Graham, G. Pirozzi, N. Stahl, and G. D. Yancopoulos. 2016. Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews. Drug Discovery 15:35–50.

Article  CAS  PubMed  Google Scholar 

Barberis, L., and E. Hirsch. 2008. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Thrombosis and Haemostasis 99:279–285.

Article  CAS  PubMed  Google Scholar 

Ghigo, A., F. Damilano, L. Braccini, and E. Hirsch. 2010. PI3K inhibition in inflammation: Toward tailored therapies for specific diseases. BioEssays 32:185–196.

Article  CAS  PubMed  Google Scholar 

Xiong, W., L. Jia, J. Liang, Y. Cai, Y. Chen, Y. Nie, et al. 2022. Investigation into the anti-airway inflammatory role of the PI3Kgamma inhibitor JN-PK1: An in vitro and in vivo study. International Immunopharmacology 111:109102.

Article  CAS  PubMed  Google Scholar 

Campa, C. C., R. L. Silva, J. P. Margaria, T. Pirali, M. S. Mattos, L. R. Kraemer, et al. 2018. Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. Nature Communications 9:5232.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu, C. Y., S. Y. Chen, Y. Deng, J. F. Song, J. H. Li, X. Chen, et al. 2021. Distinct roles of PI3Kδ and PI3Kγ in a toluene diisocyanate-induced murine asthma model. Toxicology 454:152747.

Article  CAS  PubMed  Google Scholar 

Saito, Y., M. Takeda, J. Nishikawa, Y. Konno, M. Tamaki, M. Itoga, et al. 2014. The effect of pharmacological PI3Kγ inhibitor on eotaxin-induced human eosinophil functions. Pulmonary Pharmacology & Therapeutics 27:164–169.

Article  CAS  Google Scholar 

Xiong, W., L. Jia, Y. Cai, Y. Chen, M. Gao, J. Jin, et al. 2023. Evaluation of the anti-inflammatory effects of PI3Kδ/γ inhibitors for treating acute lung injury. Immunobiology 228:152753.

Article  CAS  PubMed  Google Scholar 

Zhu, J. Y., D. Sun, X. T. Li, L. Jia, Y. F. Cai, Y. Chen, et al. 2023. Developing new PI3Kγ inhibitors by combining pharmacophore modeling, molecular dynamic simulation, molecular docking, fragment-based drug design, and virtual screening. Computational Biology and Chemistry 104:107879.

Article  CAS  PubMed  Google Scholar 

Zhu, J., K. Li, L. Xu, Y. Cai, Y. Chen, X. Zhao, et al. 2022. Discovery of novel selective PI3Kgamma inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation. Journal of Advanced Research 36:1–13.

Article  PubMed  Google Scholar 

Xue, L., C. Li, G. Ge, S. Zhang, L. Tian, Y. Wang, et al. 2021. Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma. Frontiers in Pharmacology 12:703724.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong, L., Y. Wang, T. Zheng, Y. Pu, Y. Ma, X. Qi, et al. 2021. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Research & Therapy 12:4.

Article  CAS  Google Scholar 

Liang, X., M. Deng, F. Zou, Z. Qi, C. Wang, J. Liu, et al. 2023. Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor. European Journal of Medicinal Chemistry 260:115768.

Article  CAS  PubMed  Google Scholar 

Schneble, N., C. Schmidt, R. Bauer, J. P. Müller, S. Monajembashi, and R. Wetzker. 2017. Phosphoinositide 3-kinase γ ties chemoattractant- and adrenergic control of microglial motility. Molecular and Cellular Neuroscience 78:1–8.

Article  CAS  PubMed  Google Scholar 

Orecchioni, M., Y. Ghosheh, A.B. Pramod, and K. Ley. 2019. Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages. Front Immunol 10:1084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu, L., Q. Zhao, T. Yang, W. Ding, and Y. Zhao. 2015. Cellular metabolism and macrophage functional polarization. International Reviews of Immunology 34:82–100.

Article  PubMed  Google Scholar 

Peace, C. G., and L. A. O’Neill. 2022. The role of itaconate in host defense and inflammation. The Journal of Clinical Investigation 132:e148548.

Article  CAS  PubMed